About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
CVRS - Corindus Vascular Ro...| Previous Close | Open | ||
| Volume | Market Cap | 560.16M | |
| Yield | Last Dividend |
| Analysts Estimate Corindus Vascular Robo... | 10/29/19 |
| Corindus Vascular (CVRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepa... | |
| Corindus Vascular Robotics' (CVRS) CEO M... | 08/08/19 |
| Corindus Vascular Robotics, Inc. (NYSEMKT:CVRS) Q2 2019 Earnings Conference Call August 8, 2019 8:30 AM ET Company Participants Judy DiClemente ??? In... | |
| Corindus Vascular Robotics stock rockets... | 08/08/19 |
| Shares of Corindus Vascular Robotics Inc. rocketed 76% toward a 4-year high in very active premarket trading Thursday, after the robotic-assisted vasc... | |
| Healthineers to Buy Robotics Firm Corind... | 08/08/19 |
| (Bloomberg) -- Siemens Healthineers AG plans to buy U.S. surgical firm Corindus Vascular Robotics Inc. for $1.1. billion, an acquisition aimed at broa... | |
| Germany's Siemens Healthineers buys U.S.... | 08/08/19 |
| Siemens Healthineers is buying Corindus Vascular Robotics for $1.1 billion, the companies announced on Thursday, in the biggest acquisition since the ... | |
| Corindus Vascular Robotics (CVRS) May Re... | 08/01/19 |
| Corindus Vascular (CVRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepa... | |
| Stereotaxis: Well Positioned To Become "... | 05/23/19 |
| No summary available. | |
| 95 Biggest Movers From Yesterday | 05/09/19 |
| Gainers Corindus Vascular Robotics, Inc. (NYSE: CVRS) climbed 35.71 percent to close at $2.85 on Wednesday following Q1 results. Akorn, Inc. (NASDAQ: ... | |
| Corindus Vascular up 32% on CorePath mar... | 05/08/19 |
| Corindus Vascular Robotics ([[CVRS]] +31.9%) is up on more than a 4x surge in volume on the heels of its Q1 report and update on CorPath sales. Revenu... | |
| Corindus Vascular Robotics, Inc. (DE) (C... | 05/08/19 |
| CVRS earnings call for the period ending March 31, 2019. | |
| Why Corindus Vascular Robotics Is Soarin... | 05/08/19 |
| Shares jump even though its first-quarter results fell short of Wall Street's estimates. What can explain the optimism? | |
| Corindus Vascular Robotics, Inc. (CVRS) ... | 05/07/19 |
| No summary available. | |
| Corindus Vascular Robotics (CVRS) Report... | 05/07/19 |
| Corindus Vascular (CVRS) delivered earnings and revenue surprises of 0.00% and 4.69%, respectively, for the quarter ended March 2019. Do the numbers h... | |
| DDD, QRVO MTCH and NVTA among after hour... | 05/07/19 |
| No summary available. | |
| Corindus Vascular Robotics misses by $0.... | 05/07/19 |
| No summary available. | |
| Will Corindus Vascular Robotics (CVRS) R... | 04/30/19 |
| Corindus Vascular (CVRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepa... | |
| Daily Insider Ratings Round Up 3/14/19 | 03/17/19 |
| No summary available. | |
| Daily Insider Ratings Round Up 3/13/19 | 03/15/19 |
| No summary available. | |
| Why Corindus Vascular Robotics Shares Ar... | 03/14/19 |
| News that an insider is rapidly adding to his position has the stock heading higher. | |
| Why Regulations for Clinical Trials are ... | 03/14/19 |
| PALM BEACH, Florida , March 14, 2019 /PRNewswire/ -- Recent upgrades in international and domestic regulations regarding clinical trials, are both des... | |
| More on Corindus Vascular Robotics Q4 re... | 03/13/19 |
| No summary available. | |
| Corindus Vascular Robotics, Inc. (CVRS) ... | 03/12/19 |
| No summary available. | |
| Corindus Vascular Robotics misses on rev... | 03/12/19 |
| No summary available. | |
| Corindus up 13% premarket on U.S. applic... | 02/14/19 |
| No summary available. | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Mojo Day Trading | ProTrader Mike | 46.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
